{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:54:55Z","timestamp":1761519295820,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clbc.2019.12.009","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T03:47:09Z","timestamp":1580788029000},"page":"e353-e357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5518-8747","authenticated-orcid":false,"given":"Richard","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8010-5253","authenticated-orcid":false,"given":"Lida","family":"Alarcon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9794-1602","authenticated-orcid":false,"given":"Zoltan","family":"Szollosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Lee","key":"10.1016\/j.clbc.2019.12.009_bib1"},{"year":"2016","series-title":"Clinical guidance for breast cancer screening assessment (4th edition). NHSBSP publication number 49","key":"10.1016\/j.clbc.2019.12.009_bib2"},{"key":"10.1016\/j.clbc.2019.12.009_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.crad.2018.04.004","article-title":"NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)","volume":"73","author":"Pinder","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clbc.2019.12.009_bib4","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ijc.25801","article-title":"Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening","volume":"129","author":"Rakha","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2019.12.009_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.bjc.6603714","article-title":"Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3)","volume":"96","author":"Houssami","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2019.12.009_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1245\/s10434-006-9212-8","article-title":"Predictive value of breast lesions of \u201cuncertain malignant potential\u201d and \u201csuspicious for malignancy\u201d determined by needle core biopsy","volume":"14","author":"Dillon","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2019.12.009_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2559.2003.01582.x","article-title":"Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3)","volume":"42","author":"Lee","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2019.12.009_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2559.2008.03158.x","article-title":"Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening","volume":"53","author":"El-Sayed","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2019.12.009_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejso.2018.12.008","article-title":"High risk (B3) breast lesions: what is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis","volume":"45","author":"Forester","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2019.12.009_bib10","doi-asserted-by":"crossref","first-page":"20160595","DOI":"10.1259\/bjr.20160595","article-title":"The B3 conundrum-the radiologists' perspective","volume":"90","author":"Sharma","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clbc.2019.12.009_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jclinpath-2015-203018","article-title":"Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice?","volume":"69","author":"Strachan","year":"2016","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clbc.2019.12.009_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.anndiagpath.2013.05.003","article-title":"Improved malignancy prediction by B3 breast lesions subclassification","volume":"17","author":"de Be\u00e7a","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.clbc.2019.12.009_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejso.2011.01.009","article-title":"Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast \u2013 a review","volume":"37","author":"Hussain","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2019.12.009_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pathol.2015.11.015","article-title":"Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies","volume":"48","author":"Renshaw","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.clbc.2019.12.009_bib15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/his.12081","article-title":"Outcome of pure mucocele-like lesions diagnosed on breast core biopsy","volume":"62","author":"Rakha","year":"2013","journal-title":"Histopathology"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919307682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919307682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:20:08Z","timestamp":1761513608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820919307682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1526820919307682"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.12.009","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three-year Trends in Diagnosis of B3 Breast Lesions and Their Upgrade Rates to Malignant Lesions","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}